Early-stage Alzheimer disease: getting trial-ready

PS Aisen, GA Jimenez-Maggiora, MS Rafii… - Nature Reviews …, 2022 - nature.com
Slowing the progression of Alzheimer disease (AD) might be the greatest unmet medical
need of our time. Although one AD therapeutic has received a controversial accelerated …

[HTML][HTML] Risk factors for severe COVID-19 in children: a systematic review and meta-analysis

JH Choi, SH Choi, KW Yun - Journal of Korean medical …, 2022 - synapse.koreamed.org
Background Coronavirus disease 2019 (COVID-19) has been the most important global
issue since December 2019. Although the clinical course of COVID-19 is known to be milder …

Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c+ B cells

L Malle, RS Patel, M Martin-Fernandez, OJ Stewart… - Nature, 2023 - nature.com
Down's syndrome (DS) presents with a constellation of cardiac, neurocognitive and growth
impairments. Individuals with DS are also prone to severe infections and autoimmunity …

Beschlussentwurf der STIKO zur 4. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung

S Vygen-Bonnet, J Koch, C Bogdan, T Harder… - 2021 - edoc.rki.de
Die STIKO empfiehlt die Impfung gegen COVID-19 mit einem der beiden zugelassenen
mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder …

Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome

L Malle, M Martin-Fernandez, S Buta, A Richardson… - Immunity, 2022 - cell.com
Down syndrome (DS) is typically caused by triplication of chromosome 21. Phenotypically,
DS presents with developmental, neurocognitive, and immune features. Epidemiologically …

ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification

CW Wang, HC Chuang, TH Tan - Journal of Biomedical Science, 2023 - Springer
Abstract Angiotensin-converting enzyme 2 (ACE2), a counter regulator of the renin-
angiotensin system, provides protection against several chronic diseases. Besides chronic …

Opportunities, barriers, and recommendations in Down syndrome research

JA Hendrix, A Amon, L Abbeduto… - … science of rare …, 2021 - journals.sagepub.com
BACKGROUND: Recent advances in medical care have increased life expectancy and
improved the quality of life for people with Down syndrome (DS). These advances are the …

Immunity and inflammation: the neglected key players in congenital heart disease?

LM Wienecke, S Cohen, J Bauersachs, A Mebazaa… - Heart Failure …, 2022 - Springer
Although more than 90% of children born with congenital heart disease (CHD) survive into
adulthood, patients face significantly higher and premature morbidity and mortality. Heart …

DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner

MS Strine, WL Cai, J Wei, MM Alfajaro, RB Filler… - PLoS …, 2023 - journals.plos.org
Identifying host genes essential for Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has the potential to reveal novel drug targets and further our understanding …

Immune dysregulation and the increased risk of complications and mortality following respiratory tract infections in adults with down syndrome

T Illouz, A Biragyn, MF Iulita, L Flores-Aguilar… - Frontiers in …, 2021 - frontiersin.org
The risk of severe outcomes following respiratory tract infections is significantly increased in
individuals over 60 years, especially in those with chronic medical conditions, ie …